Cardiovascular comorbidities of the 149 study patients
| Characteristic* | Delayed enhancement | No delayed enhancement | p Value |
|---|---|---|---|
| Persistent AF | 1 (20) | 66 (46) | 0.39 |
| Prior ablation | 2 (40) | 44 (31) | 0.63 |
| Prior MI | 0 (0) | 3 (2) | >0.99 |
| CAD | 0 (0) | 20 (13) | >0.99 |
| Heart failure | 0 (0) | 13 (9) | >0.99 |
| LVEF | 62 (5) | 59 (7) | 0.42 |
| Intervention, stent or bypass | 0 (0) | 17 (11) | >0.99 |
*Continuous variables expressed as mean (SD); categorical variables are expressed as number and percentage of patients.
AF, atrial fibrillation; CAD, coronary artery disease; LVEF, left ventricular ejection fraction; MI, myocardial infarction.